These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26017628)

  • 1. Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
    Dobrovolskaia MA; McNeil SE
    Expert Opin Biol Ther; 2015 Jul; 15(7):1023-48. PubMed ID: 26017628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
    Dobrovolskaia MA; McNeil SE
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1163-75. PubMed ID: 25994601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontiers in nucleic acid-based drug research and development.
    Sun LQ; Wong JP
    Future Med Chem; 2015; 7(13):1619-21. PubMed ID: 26465712
    [No Abstract]   [Full Text] [Related]  

  • 5. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
    Nakata Y; Kim TK; Shetzline S; Gewirtz AM
    Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAzyme-based therapeutics for cancer treatment.
    Fu S; Sun LQ
    Future Med Chem; 2015; 7(13):1701-7. PubMed ID: 26381244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of nucleic acid therapeutics for cancer.
    Kalota A; Shetzline SE; Gewirtz AM
    Cancer Biol Ther; 2004 Jan; 3(1):4-12. PubMed ID: 14726654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense applications for biological control.
    Pan WH; Clawson GA
    J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locked and unlocked nucleosides in functional nucleic acids.
    Doessing H; Vester B
    Molecules; 2011 May; 16(6):4511-26. PubMed ID: 21629180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.
    Bhindi R; Fahmy RG; Lowe HC; Chesterman CN; Dass CR; Cairns MJ; Saravolac EG; Sun LQ; Khachigian LM
    Am J Pathol; 2007 Oct; 171(4):1079-88. PubMed ID: 17717148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic-acid therapeutics: basic principles and recent applications.
    Opalinska JB; Gewirtz AM
    Nat Rev Drug Discov; 2002 Jul; 1(7):503-14. PubMed ID: 12120257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acids-based therapeutics in the battle against pathogenic viruses.
    Haasnoot J; Berkhout B
    Handb Exp Pharmacol; 2009; 189(189):243-63. PubMed ID: 19048203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acids as therapeutic agents.
    Alvarez-Salas LM
    Curr Top Med Chem; 2008; 8(15):1379-404. PubMed ID: 18991725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomeric nucleic acids as antivirals.
    Mescalchin A; Restle T
    Molecules; 2011 Jan; 16(2):1271-96. PubMed ID: 21278679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENA oligonucleotides as therapeutics.
    Koizumi M
    Curr Opin Mol Ther; 2006 Apr; 8(2):144-9. PubMed ID: 16610767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential application of ribozymes for the treatment of hematological disorders.
    James HA
    J Leukoc Biol; 1999 Sep; 66(3):361-8. PubMed ID: 10496304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM; Bennett CF
    Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology of antisense therapeutics.
    Jason TL; Koropatnick J; Berg RW
    Toxicol Appl Pharmacol; 2004 Nov; 201(1):66-83. PubMed ID: 15519609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.